# EDGAR Filing Document

**Accession Number:** 0001629476
**File Stem:** 0000905148-25-002297
**Filing Date:** 2025-7
**Character Count:** 19400
**Document Hash:** 8965f74d42f0ee28d1b9dd16305bf888
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000905148-25-002297.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0000905148-25-002297

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250627

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** VIKING GLOBAL INVESTORS LP
- **CENTRAL INDEX KEY:** 0001103804

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098017

**BUSINESS ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
- **BUSINESS PHONE:** 212-672-7050

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** HALVORSEN OLE ANDREAS
- **CENTRAL INDEX KEY:** 0001133006

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098012

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ott David C.
- **CENTRAL INDEX KEY:** 0001621842

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098011

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Viking Global Opportunities Portfolio GP LLC
- **CENTRAL INDEX KEY:** 0001629472

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098014

**BUSINESS ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
- **BUSINESS PHONE:** 2126727000

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901

**FORMER NAME:**
- **FORMER CONFORMED NAME:** VGO Portfolio GP LLC
- **DATE OF NAME CHANGE:** 20141230
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Viking Global Opportunities Parent GP LLC
- **CENTRAL INDEX KEY:** 0001886738

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098016

**BUSINESS ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
- **BUSINESS PHONE:** 2126727000

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Viking Global Opportunities Illiquid Investments Sub-Master LP
- **CENTRAL INDEX KEY:** 0001629482

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098013

**BUSINESS ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
- **BUSINESS PHONE:** 2126727000

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901

**FORMER NAME:**
- **FORMER CONFORMED NAME:** VGO Illiquid Investments Sub-Master LP
- **DATE OF NAME CHANGE:** 20141230
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Shabet Rose Sharon
- **CENTRAL INDEX KEY:** 0001711393

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098010

**MAIL ADDRESS:**
- **STREET 1:** 600 WASHINGTON BLVD.
- **STREET 2:** FLOOR 11
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Viking Global Opportunities GP LLC
- **CENTRAL INDEX KEY:** 0001629476

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38959
- **FILM NUMBER:** 251098015

**BUSINESS ADDRESS:**
- **STREET 1:** 55 RAILROAD AVENUE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-863-5000

**MAIL ADDRESS:**
- **STREET 1:** 55 RAILROAD AVENUE
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BridgeBio Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001743881
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3160 PORTER DR.
- **STREET 2:** SUITE 250
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94304
- **BUSINESS PHONE:** (650) 391-9740

**MAIL ADDRESS:**
- **STREET 1:** 3160 PORTER DR.
- **STREET 2:** SUITE 250
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94304

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BridgeBio Pharma LLC
- **DATE OF NAME CHANGE:** 20180618

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>VIKING GLOBAL INVESTORS LP<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Viking Global Opportunities Parent GP LLC<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Viking Global Opportunities GP LLC<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Viking Global Opportunities Portfolio GP LLC<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Viking Global Opportunities Illiquid Investments Sub-Master LP<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>HALVORSEN OLE ANDREAS<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ott David C.<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Shabet Rose Sharon<br><sub>(Last) (First) (Middle)</sub><br>600 WASHINGTON BLVD.<br>FLOOR 11<br><sub>(Street)</sub><br>STAMFORD, CT 06901<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BridgeBio Pharma, Inc. [ BBIO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-27 |  | S |  | 3500000<sup>(1)</sup> | D | $44 | 18555375<sup>(2)</sup> | I | See Explanation of Responses<sup>(3)(4)(5)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) This amount includes 155,000 shares of Common Stock sold on behalf of Viking Global Equities Master Ltd. ("VGEM"), 61,690 shares of Common Stock sold on behalf of Viking Long Fund Master Ltd. ("VLFM"), and 3,283,310 shares of Common Stock sold on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund").

(2) This amount includes 332,901 shares of Common Stock held directly by VGEM, 132,494 shares of Common Stock held directly by VLFM, and 18,089,980 shares of Common Stock held directly by Opportunities Fund.

(3) Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI"), Viking Global Performance LLC ("VGP"), which provides managerial services to VGEM, Viking Long Fund GP LLC ("VLFGP"), which provides managerial services to VLFM, and Viking Global Opportunities Parent GP LLC ("Parent"). VGI provides managerial services to various investment funds and vehicles, including VGEM, VLFM, and Opportunities Fund. Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP") is the general partner of Opportunities Fund. Viking Global Opportunities GP LLC ("Opportunities GP") is the sole member of Opportunities Portfolio GP. Parent is the sole member of Opportunities GP.

(4) Because of the relationship between each of Opportunities Portfolio GP, Opportunities GP, Parent, and Opportunities Fund, each of Opportunities Portfolio GP, Opportunities GP, and Parent may be deemed to beneficially own the shares held directly by Opportunities Fund. Because of the relationship between VGI and each of VGEM, VLFM, and Opportunities Fund, VGI may be deemed to beneficially own the shares held directly by VGEM, VLFM, and Opportunities Fund. Each of VGI, Mr. Halvorsen, Mr. Ott, and Ms. Shabet may be deemed to beneficially own all of the securities reported on this form.

(5) The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.

**Remarks:**
(6) The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. (7) Scott M. Hendler is signing on behalf of Mr. Halvorsen, Mr. Ott, and Ms. Shabet, each individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to authorization and designation letters dated February 9, 2021, which were filed with the Securities and Exchange Commission on June 7, 2021.

**Signature:** /s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen  (6)(7)  
**Date:** 2025-07-01

**Signature:** /s/ Scott M. Hendler signing on behalf of David C. Ott (6)(7)  
**Date:** 2025-07-01

**Signature:** /s/ Scott M. Hendler signing on behalf of Rose S. Shabet (6)(7)  
**Date:** 2025-07-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**